James Pantelakis, MD
Orthopaedic Surgery · Poland, OHNPI 1467440958
Payments from drug & device makers
Across 36 payments — averaging $23.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$239
- Amgen$118
- Zimmer Biomet$76
- Smith+Nephew$62
- AbbVie$61
- Mallinckrodt Enterprises LLC$52
- plus $254 from 13 others
What the payments were for
- Food & beverage$861100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 5 | $239 |
| Amgen(2 entities) | 8 | $118 |
| Zimmer Biomet | 1 | $76 |
| Smith+Nephew | 1 | $62 |
| AbbVie | 3 | $61 |
| Mallinckrodt Enterprises LLC | 2 | $52 |
| Johnson & Johnson(2 entities) | 2 | $38 |
| Bioventus LLC | 2 | $37 |
| Novartis | 2 | $27 |
| Zyla Life Sciences, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| Abbott | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Novo Nordisk | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
| Neos Therapeutics, LP | 1 | $11 |
How this compares
$861 in reported general payments places this provider in the 25th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $21,634 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 76 | $656 |
| Doxycycline Hyclate | 76 | $540 |
| Meloxicam | 178 | $520 |
| Methylprednisolone | 35 | $163 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $138 |
| Tramadol Hcl | 46 | $126 |
| Ciprofloxacin Hcl | 17 | $94 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $60 |
| Amoxicillin | 57 | $58 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Poland
- Reuben GobezieCleveland$12.6M
- Brad PichaIndependence$12.3M
- Gregory BerletWorthington$9.9M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.9M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- Mark FroimsonCleveland$2.9M
- David WelkerMiamisburg$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.